SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-17-002254
Filing Date
2017-03-29
Accepted
2017-03-29 16:34:19
Documents
5
Period of Report
2017-03-29
Effectiveness Date
2017-03-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A rigl-20170329xdef14a.htm DEF 14A 1636113
2 GRAPHIC rigl20170329xdef14a001.jpg GRAPHIC 7972
3 GRAPHIC rigl20170329xdef14a002.jpg GRAPHIC 2625
4 GRAPHIC rigl20170329xdef14a003.gif GRAPHIC 63965
5 GRAPHIC rigl20170329xdef14a004.gif GRAPHIC 61349
  Complete submission text file 0001558370-17-002254.txt   1824870
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-29889 | Film No.: 17722641
SIC: 2834 Pharmaceutical Preparations